Korean J Med Mycol.  1998 Jun;3(1):43-48.

Chronic Dermatophyte Infection Recalcitrant to Various Antifungal Agents Therapy

Affiliations
  • 1Department of Dermatology, Ajou University School of Medicine, Korea.
  • 2Dr. Shim's Skin Clinic, Suwon, Korea.

Abstract

Chronic dermatophyte infection rarely fails to respond to topical or systemic antifungal therapy. Such refractory condition relates to many factors and one of them is the decreased response of delayed type hypersensitivity. A plausible mechanism by which the delayed hypersensitivity response may cause dermatophyte inhibition has been proposed already. Our patient had skin rashes for 6 years. It was diagnosed as tinea corporis and treated with various systemic antifungal agents, such as griseofulvin, itraconazole, fluconazole, terbinafine and topical forms of econazole and terbinafine. But the skin lesions did not resolve completely and reaggravated frequently. Numerous verrucae planar were found on face, neck and both extremities. Trichophyton rubrum was identified by fungus culture study. Laboratory examination showed no response against multi-CMI test, DPCP sensitization and prick test for trichophytons. We challenged the therapy with the combined antifungal agents and immune stimulatory drugs. This case is thought to be a chronic dermatophyte infection due to the defects in the both cell mediated immunity and immediate type hypersensitivity which is crucial for the host defence mechanisms against fungal infection.

Keyword

Antifungal therapy; Chronic dermatophyte infection

MeSH Terms

Antifungal Agents*
Arthrodermataceae*
Econazole
Exanthema
Extremities
Fluconazole
Fungi
Griseofulvin
Humans
Hypersensitivity
Hypersensitivity, Delayed
Immunity, Cellular
Itraconazole
Neck
Skin
Tinea
Trichophyton
Warts
Antifungal Agents
Econazole
Fluconazole
Griseofulvin
Itraconazole
Full Text Links
  • KJMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr